Treatment of Overactive Bladder With Anticholinergic Agents

NCT07046156 · tracked via the Priya Life Science Turkey tracker

Sponsor

Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital

Phase

Observational

Started

2022-09-01

Last updated

2025-07-01

Condition(s) studied

Overactive Bladder

Investigational drug(s) / intervention(s)

Oxybutynin Clpropiverine →Tolterodine →

Oxybutynin Cl: Oxybutynin in a dose of 0.5 mg/kg will be used in the treatment of overactive bladder

propiverine: Propiverine in a dose of 0.8 mg/kg will be used in the treatment of overactive bladder

Tolterodine: Tolterodine in a dose of 0.1 mg/kg will be used in the treatment of overactive bladder

Study summary

This study aims to evaluate the efficacy and adverse effect incidence of three different anticholinergics (oxybutinin, propiverine, and tolterodine) that are used in children with overactive bladder.

Eligibility

Sex

ALL

Min age

5 Years

Max age

17 Years

Healthy volunteers

Inclusion Criteria: * Patients diagnosed with overactive bladder * Patients treated with an anticholinergic Exclusion Criteria: * Presence of anatomical or neurological problems * Patients with missing data

Primary outcome measure(s)

Number of patients treated with anticholinergic — 6 months
Number of patients with drug related adverse effects — 1 month

Trial sites (1)

Facility	City	Region	Status
Sancaktepe Sehit Prof dr Ilhan Varank Training and Research Hospital	Istanbul	Turkey (Türkiye)

More Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital trials in Turkey

Comparison of Meta-PENG and Suprainguinal Fascia Iliaca Plane Block in Hip Fractures Recruiting

Comparison of Oral Dydrogesterone and Vaginal Progesterone in Menopausal Hormone Therapy Starting soon

Comparison of Pit Picking, Phenol and Combined Pit Picking and Phenol Applications in Pilonidal Sinus Treatment Recruiting

Measurement of Ultrasonographic Rectal Diameter in Children With Constipation Active, not recruiting

Bladder Wall Thickness for Treatment Response in Children With Lower Urinary Tract Dysfunction or Enuresis Active, not recruiting

Other trials for the same condition

The Efficacy of Transcutaneous Tibial Nerve Stimulation in Women With Idiopathic Overactive Bladder Enrolling by invitation

Investigation of Effects of Electrical Stimulation in Women With Vaginal Laxity Recruiting

SGLT-2 Inhibitors and Lower Urinary Tract Symptoms Active, not recruiting

The Role of Urinary RhoA, NGF, and BDNF Levels in Overactive Bladder and Vitamin D Deficiency Starting soon

Transcutaneous Tibial Nerve Stimulation for Idiopathic Overactive Bladder Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07046156 on ClinicalTrials.gov ↗ ← All trials in Turkey